The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis

References

• Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995;222:120-7
   PubMed Web of Science ®Google Scholar
• Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994;107:1856-60
   PubMed Web of Science ®Google Scholar
• Hurst RD, Molinari M, Chung TP, et al. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996;131:497-500; discussion 501-2
   PubMed Web of Science ®Google Scholar
• Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 1998;85:800-3
   PubMed Web of Science ®Google Scholar
• Penna C, Dozois R, Tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996;38:234-9
   PubMed Web of Science ®Google Scholar
• Simchuk EJ, Thirlby RC. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J Surg 2000;24:851-6
   PubMed Web of Science ®Google Scholar
• Shen B, Fazio VW, Remzi FH, Lashner BA. Clinical approach to diseases of ileal pouch-anal anastomosis. Am J Gastroenterol 2005;100:2796-807
   PubMed Web of Science ®Google Scholar
• Stahlberg D, Gullberg K, Liljeqvist L, et al. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996;39:1012-18
   PubMed Web of Science ®Google Scholar
• Svaninger G, Nordgren S, Oresland T, Hulten L. Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch. Scand J Gastroenterol 1993;28:695-700
   PubMed Web of Science ®Google Scholar
• Shen B, Achkar JP, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001;121:261-7
   PubMed Web of Science ®Google Scholar
• Pardi DS, Shen B. Endoscopy in the management of patients after ileal pouch surgery for ulcerative colitis. Endoscopy 2008;40:529-33
   PubMed Web of Science ®Google Scholar
• Moskowitz RL, Shepherd NA, Nicholls RJ. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986;1:167-74
   PubMed Web of Science ®Google Scholar
• Shepherd NA, Jass JR, Duval I, et al. Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens. J Clin Pathol 1987;40:601-7
   PubMed Web of Science ®Google Scholar
• Pardi DS, D’Haens G, Shen B, et al. Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis 2009;15:1424-31
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 1994;69:409-15
   PubMed Web of Science ®Google Scholar
• Shen B. Pouchitis: what every gastroenterologist needs to know. Clin Gastroenterol Hepatol 2013;11:1538-49
   PubMed Web of Science ®Google Scholar
• Landy J, Al-Hassi HO, McLaughlin SD, et al. Etiology of pouchitis. Inflamm Bowel Dis 2012;18:1146-55
   PubMed Web of Science ®Google Scholar
• Batista D, Raffals L. Role of intestinal bacteria in the pathogenesis of pouchitis. Inflamm Bowel Dis 2014;20:1481-6
   PubMed Web of Science ®Google Scholar
• Nicholls RJ, Belliveau P, Neill M, et al. Restorative proctocolectomy withileal reservoir: a pathophysiological assessment. Gut 1981;22:462-8
   PubMed Web of Science ®Google Scholar
• Santavirta J, Mattila J, Kokki M, et al. Mucosal morphology and fecal bacteriology after ileoanal anastomosis. Int J Colorectal Dis 1991;6(1):38-41
   PubMed Web of Science ®Google Scholar
• Ruseler-van Embden JG, Schouten WR, van Lieshout LM. Pouchitis: result of microbial imbalance? Gut 1994;35:658-64
   PubMed Web of Science ®Google Scholar
• Meier CB, Hegazi RA, Aisenberg J, et al. Innate immune receptor genetic polymorphisms in pouchitis: is CARD15 a susceptibility factor? Inflamm Bowel Dis 2005;11:965-71
   PubMed Web of Science ®Google Scholar
• Tyler AD, Milgrom R, Stempak JM, et al. The NOD2insC polymorphismis associated with worse outcome following ileal pouch-anal anastomosisfor ulcerative colitis. Gut 2013;62:1433-9
   PubMed Web of Science ®Google Scholar
• Carter MJ, Di Giovine FS, Cox A, et al. The interleukin 1 receptorantagonist gene allele 2 as a predictor of pouchitis following colectomyand IPAA in ulcerative colitis. Gastroenterology 2001;121:805-11
   PubMed Web of Science ®Google Scholar
• Lammers KM, Ouburg S, Morre SA, et al. Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis. World J Gastroenterol 2005;11:7323-9
   PubMed Web of Science ®Google Scholar
• Navaneethan U, Shen B. Secondary pouchitis: those with idenfiable etiopathogenetic or triggering factors. Am J Gastroenterol 2010;105:51-64
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Lammers KM, et al. Antibiotics and probiotics in treatment of inflammatory bowel diseases. World J Gastroenterol 2006;12:3306-13
   PubMed Web of Science ®Google Scholar
• Lee YK, Salminen S. The coming age of probiotics. Trends Food Sci Technol 1995;6:241-5
   Web of Science ®Google Scholar
• Ng SC, Hart AL, Kamm MA, et al. Mechanism of action of probiotics: recent advances. Inflamm Bowel Dis 2009;15:300-10
   PubMed Web of Science ®Google Scholar
• Madden MV, McIntyre AS, Nicholls RJ. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994;39:1193-6
   PubMed Web of Science ®Google Scholar
• Shen B, Achkar JP, Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001;7:301-5
   PubMed Web of Science ®Google Scholar
• Holubar SD, Cima RR, Sandborn WJ, Pardi DS. Treatment and prevention of pouchitis after ileal-pouch anal anastomosis for ulcerative colitis. Cochrane Database Sys Rev 2010;6:CD001176
   PubMedGoogle Scholar
• Isaacs KL, Sandler RS, Abreu M, et al. Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 2007;13:1250-5
   PubMed Web of Science ®Google Scholar
• Kuisma J, Mentuls S, Jarvinen H, et al. Effect of lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol Ther 2003;17:509-15
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Morselli C, et al. High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum 2007;50:2075-82
   PubMed Web of Science ®Google Scholar
• Van Assche G, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations. J Crohn’s Colit 2013;7:1-33
   PubMed Web of Science ®Google Scholar
• Shen B, Fazio VW, Remzi FH, et al. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. Dis Colon Rectum 2007;50:498-508
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999;13:713-18
   PubMed Web of Science ®Google Scholar
• Abdelrazeq AS, Kelly SM, Lund JN, Leveson SH. Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis. Colorectal Dis 2005;7:182-6
   PubMed Web of Science ®Google Scholar
• Mimura T, Rizzello F, Helwig U, et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002;16:909-17
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119:305-9
   PubMed Web of Science ®Google Scholar
• Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004;53:108-14
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003;124:1202-9
   PubMed Web of Science ®Google Scholar
• Shen B, Brzezinski A, Fazio VW, et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment Pharmacol Ther 2005;22:721-8
   PubMed Web of Science ®Google Scholar
• Persborn M, Gerritsen J, Wallon C, et al. The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. Aliment Pharmacol Ther 2013;38:772-83
   PubMed Web of Science ®Google Scholar
• Kuhbacher T, Ott SJ, Helwig U, et al. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 2006;55:833-41
   PubMed Web of Science ®Google Scholar
• McLaughlin SD, Clark SK, Bell AJ, et al. An open study of antibiotics for the treatment of pre-pouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis. Aliment Pharmacol Ther 2009;29:69-74
   PubMed Web of Science ®Google Scholar